Looking for HLA-G expression in human tumours

Journal of Reproductive Immunology

Volumn 43, Issue 2, 1999, Pages 263-273

  Real, Luis Miguel ^a   Cabrera, Teresa ^a   Canton, Julia ^a   Oliva, Rosario ^a   Ruiz Cabello, Francisco ^a   Garrido, Federico ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

HLA G expression; Human tumors; NK lysis

Indexed keywords

HLA G ANTIGEN; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NATURAL KILLER CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR CELL LINE;

GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032799441     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(99)00038-8     Document Type: Article

References (14)

1. Amiot, L., Onno, M., Drenou, B., Lamy, T., Fauchet, R. 1998. Expression of HLA-G in malignant hematopoietic cells. 1st Int. Conf. on HLA-G, 6-7 July, Paris, France.
2. Benitez R., Gudelaine D., Lopez-Nevol M.A. et al. Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens. 52:1998;520-529.
3. Bicknell D.C., Rowan A., Bodmer W.F. 2-Microglobulin gene mutations: a study of established colorectal cell lines and fresh tumours. Proc. Natl. Acad. Sci. USA. 91:1994;4751-4755.
4. Cabrera T., Fernández M.A., Sierra A. et al. High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum. Immunol. 50:1996;127-134.
5. Farrell H.E., Vally H., Lynch D.M. et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 386:1997;510-514.
6. Frumento, G., Franchello, S., Geragthy, E., Ferrara, G.B. 1998. Analysis of HLA-G expression in tumour cell lines. 1st Int. Conf. on HLA-G, 6-7 July, Paris, France.
7. Garrido F., Cabrera T., Lopez-Nevot M.A., Ruiz-Cabello F. HLA class I antigens in human tumours. Adv. Cancer Res. 67:1995;155-195.
8. Garrido F., Ruiz-Cabello F., Cabrera T. et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today. 18:1997;89-95.
9. Kirkin A.F., Petersen T.R., Olsen A.C., Per thor Straten L.L., Zeuthen J. Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol. Immunother. 41:1995;71-81.
10. Kirszenbaum M., Philippe M., Gluckman E., Dausset J., Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sci. USA. 91:1994;4209-4213.
11. Paul P., Rouas-Freis N., Khalil-Daher I. et al. HLA-G expression in melanomas: a way for tumour cells to escape from immunosurveillance. Proc. Natl. Acad. Sci. USA. 95:1998;4510-4515.
12. Real L.M., Jimenez P., Canton J. et al. In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class I allele. Int. J. Cancer. 75:1998;317-323.
13. Reyburn H.T., Mandelboim O., Vales-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:1997;514-517.
14. Torres M.J., Ruiz-Cabello F., Skoudy A. et al. Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumour derived cell line. Tissue Antigens. 47:1996;372-381.